Search Browse Earnings

Journey Medical Corp

Nasdaq:DERM

Pharmaceutical Preparations·SCOTTSDALE, AZ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Journey Medical Corp — SlamSEC

Revenue

$59.7M

-16.0% YoY

FY 2024

Adj. EBITDA

-$2.1M

-3.5% margin

FY 2024

Net Income

-$3.9M

-6.5% margin

FY 2024

EPS (Diluted)

-$0.21

FY 2024

Stock Price

$7.74

-1.4%

2026-03-06

52W Range

$4.97 – $9.55

P/E Ratio

-36.9x

Market Cap

—

Cash

$27.4M

FY 2024

Total Debt

$14.6M

FY 2024

Net Cash

$12.8M

FY 2024

Enterprise Value

—

Debt / EBITDA

6.2x

FY 2024

EV / EBITDA

—

Employees

—

CEO

Maraoui Claude